The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs
The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs
复制标题
DOI:
10.1107/s0907444905015404
复制
发表时间:
2005-07-01
影响因子:
2.2
通讯作者:
Coll, M
中科院分区:
文献类型:
--
作者:
Canals, A;Purciolas, M;Coll, M
Ellipticine is a natural plant product that has been found to be a powerful anticancer drug. Although still unclear, its mechanism of action is considered to be mainly based on DNA intercalation and/or the inhibition of topoisomerase II. Many experimental data suggest an intercalation based on stacking interactions along the major base-pair axis, but alternative binding modes have been proposed, in particular for ellipticine derivatives. The 1.5 angstrom resolution structure of ellipticine complexed to a 6 bp oligonucleotide unveils its mode of binding and enables a detailed analysis of the distorting effects of the drug on the DNA.